Key result
Cardiac magnetic resonance imaging and endomyocardial biopsy successfully identified eosinophilic myocarditis in a 20-year-old male presenting with heart failure and an ejection fraction of 40%.
Why the study?
Eosinophilic myocarditis secondary to EGPA is rare, and differentiating it from COVID-19-associated myocarditis poses a clinical diagnostic challenge.
Population
One 20-year-old Hispanic male recently recovered from COVID-19 presenting with pleuritic chest pain and dyspnoea
Design
Case report
Authors
Loading...
May support CMRI and EMB to differentiate EM from COVID-19 myocarditis; leaves open prospective validation.
Case Report (n=1)
CMRI is a critical non-invasive modality for diagnosing eosinophilic myocarditis and differentiating it from COVID-19-associated myocarditis.
Rao et al. (2023) conducted a case report in Eosinophilic myocarditis (n=1). Cardiac magnetic resonance imaging (CMRI) was evaluated on Diagnosis of eosinophilic myocarditis. Cardiac magnetic resonance imaging and endomyocardial biopsy successfully identified eosinophilic myocarditis in a 20-year-old male presenting with heart failure and an ejection fraction of 40%.